Course Handbook  Course Handbook

Advanced Patent Prosecution Workshop 2018: Claim Drafting & Amendment Writing

Publication Date: July 2018 Number of Volumes: 1
ISBN Number: 9781402432019 Page Count: 1216 pages

From: Advanced Patent Prosecution Workshop 2018: Claim Drafting & Amendment Writing

Download: Table of Contents    Index

Table of Contents
Chapter 1: Conflicts of Interest in Patent Acquisition and Patent Litigation Representation (April 28, 2016) Robert C Faber ~ Ostrolenk Faber LLP
Chapter 2: Prosecution Ethics, Including Therasense v. Becton Dickinson (April 28, 2016) Robert C Faber ~ Ostrolenk Faber LLP
Chapter 3: Supplemental Examination Robert C Faber ~ Ostrolenk Faber LLP
Chapter 4: Specification Drafting: The Story Behind the Invention—Biotechnology Edition (May 1, 2018) John Petravich ~ Deputy General Counsel & Vice President of Intellectual Property, Integrated DNA Technologies, Inc.
Chapter 5: Specification Drafting for the Chemical/Pharmaceutical Patent Application Keith D MacMillan ~ Director (Counsel), Legal, Merck & Co
Chapter 6: The Great Specification Balancing Act Rebecca Goldman Rudich ~ Meunier Carlin & Curfman LLC
Chapter 7: Drafting the Specification Kenneth N Nigon ~ Schwegman Lundberg & Woessner, P.A.
Chapter 8: Antibody Claim Drafting: Reaching the End of the “Antibody Exception” Steven P Lendaris ~ Baker Botts LLP
Chapter 9: Advanced Claim Drafting Issues for Biotechnology Patent Applications Sharon M Sintich ~ Marshall, Gerstein &Borun LLP
Chapter 10: Chemical and Pharmaceutical Claim Drafting 2018 George Wheeler ~ McAndrews, Held & Malloy, Ltd.
Chapter 11: Chemical and Pharmaceutical Claim Drafting 2018 (PowerPoint slides) George Wheeler ~ McAndrews, Held & Malloy, Ltd.
Chapter 12: ElectroMechanical Arts Claim under Section § 101 of the Patent Act (April 28, 2016) Robert C Faber ~ Ostrolenk Faber LLP
Chapter 13: § 112 (f) and the Current Status of “Means for”, “Step for” and “Nonce” Word Claim Elements (April 28, 2016) Robert C Faber ~ Ostrolenk Faber LLP
Chapter 14: The Winning Mechanical Claim (April 28, 2016) Robert C Faber ~ Ostrolenk Faber LLP
Chapter 15: Techniques for Responding to Obviousness Rejections (2018) Lawrence H Aaronson ~ McDonnell Boehnen Hulbert & Berghoff LLP
Chapter 16: Ann M. McCrackin, Steven W. Lundberg and Gregory M. Stark, Crafting the Claims Ann M McCrackin ~ Schwegman Lundberg & Woessner, P.A.
Chapter 17: WebEx Interviews at the USPTO Kenneth N Nigon ~ Schwegman Lundberg & Woessner, P.A.
Chapter 18: United States Patent and Trademark Office, Interview Specialist List Claire X Pappas ~ Supervisory Patent Examiner, United States Patent and Trademark Office
Kenneth N Nigon ~ Schwegman Lundberg & Woessner, P.A.
Chapter 19: Timothy Callahan, United States Patent and Trademark Office, Face-to-Face Examiner Interviews: A Demonstration of USPTO Tools Claire X Pappas ~ Supervisory Patent Examiner, United States Patent and Trademark Office
Kenneth N Nigon ~ Schwegman Lundberg & Woessner, P.A.
Chapter 20: Post-Grant Proceedings at the USPTO: Prefiling Considerations and Effectively Defending Against a Petition, Excerpts from Chapters 2–5 of the PLI Publication, Post-Grant Proceedings Before the Patent Trial and Appeal Board (October 2016) W. Todd Baker ~ Oblon, McClelland, Maier & Neustadt, L.L.P.
Chapter 21: Claim Drafting for Biotechnology Patent Applications Gerard F Diebner ~ Tannenbaum Helpern Syracuse & Hirschtritt LLP
Chapter 22: Update on Patent Agent Privilege Deborah L Lu ~ Vedder Price P.C.
Chapter 23: The Use of “Means Plus Function” Language in Patent Claims Robert D Schaffer ~ Law Office of Robert D. Schaffer
Chapter 24: The Use of “Means Plus Function” Language in Patent Claims (PowerPoint slides) Robert D Schaffer ~ Law Office of Robert D. Schaffer
Chapter 25: Responding to the “Difficult” Obviousness Rejection Michael P Dunnam ~ Schwegman Lundberg & Woessner, P.A.
Chapter 26: Claiming Strategies for Fintech and Business Methods: Plan Ahead for Patent Eligibility Rejections (April 16, 2018) Michael P Dunnam ~ Schwegman Lundberg & Woessner, P.A.
Chapter 27: Conducting Interviews at the U.S. Patent and Trademark Office Jay P Lessler ~ Blank Rome LLP
Chapter 28: United States Patent and Trademark Office, Interview Best Practices Claire X Pappas ~ Supervisory Patent Examiner, United States Patent and Trademark Office
Kenneth N Nigon ~ Schwegman Lundberg & Woessner, P.A.
Chapter 29: United States Patent and Trademark Office, Interview Practice Training Summary: Effective Interview Practice Claire X Pappas ~ Supervisory Patent Examiner, United States Patent and Trademark Office
Kenneth N Nigon ~ Schwegman Lundberg & Woessner, P.A.
Chapter 30: Patent Term Adjustment and Recent Legal Developments J. Robert Dean ~ Ohlandt, Greeley, Ruggiero & Perle, L.L.P.
Chapter 31: Ethics Issues for Patent Prosecutors Burt Magen ~ Vierra Magen Marcus LLP
Chapter 32: The New Section 102—Exploring the Changes Renee DuBord Brown ~ Associate General Counsel, Intellectual Property , Knowles Electronics
Chapter 33: Article of Manufacture Claims for Computer Related Inventions Burt Magen ~ Vierra Magen Marcus LLP
Chapter 34: Advanced Claim Drafting Issues (PowerPoint slides) Burt Magen ~ Vierra Magen Marcus LLP
Chapter 35: Advanced Claim Drafting Issues (Personalized/Precision Medicine) (May 4, 2018) Roger C Kuan ~ McDermott Will & Emery LLP
Chapter 36: Advanced Claim Drafting Issues (Personalized/Precision Medicine) (PowerPoint slides) Roger C Kuan ~ McDermott Will & Emery LLP
Chapter 37: Subject Matter Eligibility in the Life Sciences (Especially in View of Language) Tom Anderton ~ Squire Patton Boggs (US) LLP
Chapter 38: Responding to the Obviousness Rejection Judith Szepesi ~ HIPLegal LLP
Chapter 39: Overcoming Obviousness Rejections under 35 U.S.C. §103 Melissa M Harwood ~ Wilson Sonsini Goodrich & Rosati
Chapter 40: Advanced Issues in Patent Specification Drafting Christopher M Tobin ~ Michael Best & Friedrich LLP
Chapter 41: Unpacking the Written Description Requirement Pauline Farmer-Koppenol ~ Associate General Counsel - Patents , Bio-Rad Laboratories, Inc.
Chapter 42: Amgen Inc., Amgen Manufacturing Limited, Amgen USA, Inc. v. Sanofi, Aventisub LLC, Regeneron Pharmaceuticals Inc., Sanofi-Aventis U.S., LLC, No. 2017-1480 (Fed. Cir. Oct. 5, 2017) Pauline Farmer-Koppenol ~ Associate General Counsel - Patents , Bio-Rad Laboratories, Inc.
Chapter 43: What a Litigator Hates to See in the Prosecution History of a Patent Jeffrey A Miller ~ Arnold & Porter Kaye Scholer LLP
Chapter 44: What a Litigator Hates to See in the Prosecution History of a Patent (PowerPoint slides) Jeffrey A Miller ~ Arnold & Porter Kaye Scholer LLP
Index

This Course Handbook was compiled for the program, Advanced Patent Prosecution Workshop 2018 Claim Drafting Amendment Writing.

PLI’s nationally acclaimed course handbooks represent the definitive thinking of the nation’s finest legal minds on timely topics and are considered the standard reference in the field. This course handbook is prepared specifically for the program and stands alone as a permanent reference.

Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • YouTube
  • RSS

All Contents Copyright © 1996-2018 Practising Law Institute. Continuing Legal Education since 1933.

© 2018 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.